SNN - Smith & Nephew plc

NYSE - NYSE Delayed Price. Currency in USD
38.01
-0.49 (-1.27%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close38.50
Open38.20
Bid37.64 x 400
Ask37.69 x 3000
Day's Range37.97 - 38.36
52 Week Range26.97 - 40.43
Volume650,823
Avg. Volume525,087
Market Cap16.01B
Beta0.50
PE Ratio (TTM)19.35
EPS (TTM)1.96
Earnings DateN/A
Dividend & Yield0.62 (1.72%)
Ex-Dividend Date2017-03-29
1y Target Est39.42
Trade prices are not sourced from all markets
  • Elliott Said to Build Stake in Smith & Nephew
    Bloomberg Video6 days ago

    Elliott Said to Build Stake in Smith & Nephew

    Oct.11 -- Activist investor Paul Singer is honing in on Europe, building stakes in an engineering and healthcare company. An after hour statement revealed Singer's hedge fund Elliott Management added German engineering firm GEA to its portfolio and according to people familiar with the matter, it also took a stake in the British company Smith & Nephew. Bloomberg's Ruth David reports on "Bloomberg Markets: European Open."

  • Financial Times6 days ago

    [$$] Elliott Management takes stakes in GEA and Smith & Nephew

    Elliott Management, Paul Singer's US hedge fund, has stepped up its activist campaigning in Europe, taking stakes in German food-processing machinery maker GEA and UK medical device maker Smith & Nephew. ...

  • Financial Times6 days ago

    [$$] Smith & Nephew: hippy hippy shake-up

    At 20 times forecast profits, shares in Smith & Nephew are rated like a growth stock. Yet adjusted earnings grew just 2 per cent a year between 2011 and 2016. Takeover speculation explains the divergence. ...

  • TheStreet.com6 days ago

    Smith & Nephew Surges to Record High on Reports of Elliott Stake

    Paul Singer's Elliott is said to have started building a stake in the maker of artificial hips and knees, sending shares higher.

  • Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark
    Investor's Business Daily6 days ago

    Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Why MannKind, Nutanix, and Smith & Nephew Jumped Today
    Motley Fool7 days ago

    Why MannKind, Nutanix, and Smith & Nephew Jumped Today

    On a sunny day for the market, these stocks gained ground. Find out why.

  • Reuters7 days ago

    Elliott Management builds stake in Smith & Nephew - Bloomberg

    It is unclear how much stake the activist investor owns or what it plans to push for at the company, according to the Bloomberg report. "We do not comment on rumour or speculation and we do not comment on the identity of our investors other than those publicly disclosed," Smith & Nephew said in an emailed statement. Elliott declined to comment.

  • Elliott's Deal Magic Is Put to the Test
    Bloomberg7 days ago

    Elliott's Deal Magic Is Put to the Test

    The hedge fund has taken a stake in Smith & Nephew, which year after year has disappointed M&A speculators.

  • Singer's Elliott Builds a Stake in Smith & Nephew
    Bloomberg7 days ago

    Singer's Elliott Builds a Stake in Smith & Nephew

    Billionaire Paul Singer’s hedge fund Elliott Management Corp. has built a stake in Smith & Nephew Plc, the maker of artificial hips and knees, according to people familiar with the matter.

  • Stocks Showing Improved Relative Strength: Smith & Nephew
    Investor's Business Daily12 days ago

    Stocks Showing Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks
    Zacks14 days ago

    Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks

    Zeroing in on dividend stocks with a solid Zacks Rank is a great way to increase the chances of beating volatile market conditions while ensuring a steady stream of cash flow. Here are three top picks in the MedTech space.

  • Capital Cube14 days ago

    ETFs with exposure to Smith & Nephew Plc : October 3, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew
    Zacks25 days ago

    The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew

    The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew

  • Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy
    Zacks27 days ago

    Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy

    The fate of Obamacare will be decided on Sep. 30. No matter what the future holds, the day will provide investors a clear picture of where the MedTech industry is headed.

  • Capital Cubelast month

    ETFs with exposure to Smith & Nephew Plc : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • 5 British Stocks to Profit From a Weak Pound Sterling
    Zackslast month

    5 British Stocks to Profit From a Weak Pound Sterling

    Companies exporting products and services stand to benefit from a weaker pound.

  • Capital Cube2 months ago

    ETFs with exposure to Smith & Nephew Plc : August 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Barrons.com2 months ago

    [$$] Medical Tech Bounces Back in Emerging Markets

    Wells Fargo Securities The median constant currency growth rate of the large-cap medical-tech companies in emerging markets (EM) was around 11% in the second quarter. The high median growth was due to nearly across the board sequential improvements in EM growth, which also drove up the average EM growth from about 9% in the first quarter to about 10% in the second quarter, The median EM growth of the large-cap med-tech companies continues to outpace the overall world-wide organic growth rate of 3.5% in the second quarter. The year-over-year (excluding exchange rates) growth of 3.5% for the large-cap med-tech sector in the quarter was the lowest rate we’ve seen since we began tracking this metric in the calendar first-quarter of 2015.

  • Capital Cube2 months ago

    ETFs with exposure to Smith & Nephew Plc : August 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Smith & Nephew Plc :SNN-US: Earnings Analysis: For the six months ended June 30, 2017 : July 31, 2017
    Capital Cube3 months ago

    Smith & Nephew Plc :SNN-US: Earnings Analysis: For the six months ended June 30, 2017 : July 31, 2017

    Categories: Yahoo FinanceGet free summary analysis Smith & Nephew Plc reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of Smith & Nephew Plc – Zimmer Biomet Holdings, Inc., Johnson & Johnson, Edwards Lifesciences Corporation, Boston Scientific Corporation, Stryker Corporation, C. R. Bard, Inc., Exactech, Inc. and ... Read more (Read more...)

  • Reuters3 months ago

    Robot wars: knee surgery marks new battleground for companies

    The world's top medical technology companies are turning to robots to help with complex knee surgery, promising quicker procedures and better results in operations that often leave patients dissatisfied. Demand for artificial replacement joints is growing fast, as baby boomers' knees and hips wear out, but for the past 15 years rival firms have failed to deliver a technological advance to gain them significant market share.

  • Smith & Nephew expands NAVIO™ Robotics-assisted surgery system into Total Knee replacements
    PR Newswire4 months ago

    Smith & Nephew expands NAVIO™ Robotics-assisted surgery system into Total Knee replacements

    LONDON , June 29, 2017 /PRNewswire/ -- Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the launch of its NAVIO handheld robotics-assisted total knee arthroplasty ...

  • Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye
    PR Newswire4 months ago

    Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye

    KING OF PRUSSIA, Pa., June 6, 2017 /PRNewswire/ -- Trice Medical announced today that it closed a $19.3 million Series C financing and will use the proceeds to accelerate and expand the company's U.S. market penetration for mi-eye2™, R&D, sales, marketing and key international regulatory approvals. Smith & Nephew (LSE:SN, NYSE:SNN), a global medical technology business dedicated to helping healthcare professionals improve people's lives, has taken a minority stake joining a consortium of current investors including Safeguard Scientifics (SFE), HealthQuest Capital, BioStar Ventures and others in this latest funding round. To-date, Trice Medical has raised $40.9 million.

  • 3 Best Dividend Stocks in the Medical Device Industry
    Motley Fool4 months ago

    3 Best Dividend Stocks in the Medical Device Industry

    Looking for solid dividend stocks in the medical device industry? Check out Abbott Labs, Medtronic, and Smith & Nephew.